HIYAM ABDELMAGID: Open Payments
NPI 1174979157 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,593 in 84 payments from 19 companies in 2025. Trend: 2023 $1,976 · 2024 $2,263 · 2025 $1,593
Food & beverage: $1,593
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $395 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $166 |
| AstraZeneca Pharmaceuticals LP | 6 | $165 |
| Amgen Inc. | 9 | $139 |
| Astellas Pharma US Inc | 5 | $97 |
| Novo Nordisk Inc | 4 | $95 |
| UCB, Inc. | 3 | $89 |
| Abbott Laboratories | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $57 |
Products named: NURTEC ODT, Kerendia, EVENITY, AIRSUPRA, ELIQUIS, Veozah, Bimzelx, Wegovy.
Industry payments across FL — which companies pay providers there.
